The balance between stroke prevention and bleeding risk in atrial fibrillation - A delicate balance revisited

被引：14

作者：

Lip, Gregory Y. H. ^{[1
]}

机构：

[1] Univ Birmingham, City Hosp, Dept Med, Birmingham B18 7QH, W Midlands, England

来源：

STROKE | 2008年 / 39卷 / 05期

关键词：

atrial fibrillation; bleeding anticoagulation; stroke; thromboembolism;

D O I：

10.1161/STROKEAHA.107.506832

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：1406 / 1408

页数：3

共 20 条

[1] Can patients at elevated risk of stroke treated with anticoagulants be further risk stratified? [J].

Baruch, Lawrence ;

Gage, Brian F. ;

Horrow, Jay ;

Juul-Moller, Steen ;

Labovitz, Arthur ;

Persson, Maria ;

Zabalgoitia, Miguel .

STROKE, 2007, 38 (09) :2459-2463

[2] Atrial fibrillation and the hypercoagulable state: From basic science to clinical practice [J].

Choudhury, A ;

Lip, GYH .

PATHOPHYSIOLOGY OF HAEMOSTASIS AND THROMBOSIS, 2003, 33 (5-6) :282-289

[3] ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation -: executive summary -: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients with Atrial Fibrillation) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society [J].

Fuster, Valentin ;

Ryden, Lars E. ;

Cannom, David S. ;

Crijns, Harry J. ;

Curtis, Anne B. ;

Ellenbogen, Kenneth A. ;

Halperin, Jonathan L. ;

Le Heuzey, Jean-Yves ;

Kay, G. Neal ;

Lowe, James E. ;

Olsson, S. Bertil ;

Prystowsky, Eric N. ;

Tamargo, Juan Luis ;

Wann, Samuel ;

Priori, Silvia G. ;

Blanc, Jean-Jacques ;

Budaj, Andrzej ;

Camm, John ;

Dean, Veronica ;

Deckers, Jaap W. ;

Despres, Catherine ;

Dickstein, Kenneth ;

Lekakis, John ;

McGregor, Keith ;

Metra, Marco ;

Morais, Joao ;

Osterspey, Ady ;

Tamargo, Juan Luis ;

Zamorano, Jose Luis ;

Smith, Sidney C. ;

Jacobs, Alice K. ;

Adams, Cynthia D. ;

Anderson, Jeffery L. ;

Antman, Elliott M. ;

Halperin, Jonathan L. ;

Hunt, Sharon Ann ;

Nishimura, Rick ;

Ornato, Joseph P. ;

Page, Richard L. ;

Riegel, Barbara .

EUROPEAN HEART JOURNAL, 2006, 27 (16) :1979-2030

[4] Selecting patients with atrial fibrillation for anticoagulation - Stroke risk stratification in patients taking aspirin [J].

Gage, BF ;

van Walraven, C ;

Pearce, L ;

Hart, RG ;

Koudstaal, PJ ;

Petersen, P .

CIRCULATION, 2004, 110 (16) :2287-2292

[5] Risks and benefits of oral anticoagulation compared with clopidogrel plus aspirin in patients with atrial fibrillation according to stroke risk - The atrial fibrillation clopidogrel trial with irbesartan for prevention of vascular events (ACTIVE-W) [J].

Healey, Jeff S. ;

Hart, Robert G. ;

Pogue, Janice ;

Pfeffer, Marc A. ;

Hohnloser, Stefan H. ;

De Caterina, Raffaele ;

Flaker, Greg ;

Yusuf, Salim ;

Connolly, Stuart J. .

STROKE, 2008, 39 (05) :1482-1486

[6] Risk factors for anticoagulation-related bleeding complications in patients with atrial fibrillation: a systematic review [J].

Hughes, M. ;

Lip, G. Y. H. .

QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2007, 100 (10) :599-607

[7] Stroke and thromboembolism in atrial fibrillation: A systematic review of stroke risk factors, risk stratification schema and cost effectiveness data [J].

Hughes, Michael ;

Lip, Gregory Y. H. .

THROMBOSIS AND HAEMOSTASIS, 2008, 99 (02) :295-304

[8] Major Hemorrhage and tolerability of warfarin in the first year of therapy among elderly patients with atrial fibrillation [J].

Hylek, Elaine M. ;

Evans-Molina, Carmella ;

Shea, Carol ;

Henault, Lori E. ;

Regan, Susan .

CIRCULATION, 2007, 115 (21) :2689-2696

[9] A prospective randomized trial of aspirin-clopidogrel combination therapy and dose-adjusted warfarin on indices of thrombogenesis and platelet activation in atrial fibrillation [J].

Kamath, S ;

Blann, AD ;

Chin, BSP ;

Lip, GYH .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 40 (03) :484-490

[10] Additive role of plasma von Willebrand factor levels to clinical factors for risk stratification of patients with atrial fibrillation (vol 37, pg 2294, 2006) [J].

Lip .

STROKE, 2006, 37 (09) :2444-2444

← 1 2 →